Search Within

Shakeel Modak

  1. "Neuroblastoma Service"
Formats
  1. Journal Article (136)
  2. Meeting Abstract (109)
  3. Book Section (3)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Neuroblastoma Service (250)
  2. Pediatrics, Department of (250)
  3. GSK Faculty (183)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (181)
  5. Tow Center for Developmental Oncology (TCDO) (177)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (171)

More Groups

People
  1. Nai-Kong Cheung (169)
  2. Brian Kushner (155)
  3. Kim Kramer (105)
  4. Ellen Basu (77)
  5. Stephen Roberts (68)
  6. Michael La Quaglia (57)

More People

Years
  1. 2025 (3)
  2. 2024 (11)
  3. 2023 (15)
  4. 2022 (13)
  5. 2021 (12)
  6. 2020 (13)

More Years

Publications
  1. Pediatric Blood and Cancer (69)
  2. Journal of Clinical Oncology (35)
  3. International Journal of Radiation Oncology, Biology, Physics (15)
  4. Neuro-Oncology (11)
  5. Journal of Nuclear Medicine (9)
  6. Journal of Pediatric Hematology/Oncology (8)

More Publications

Publishers
  1. Wiley Periodicals, Inc (69)
  2. American Society of Clinical Oncology (36)
  3. Elsevier Inc. (23)
  4. American Association for Cancer Research (17)
  5. Lippincott Williams & Wilkins (12)
  6. Oxford University Press (11)

More Publishers

Results (250)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long prime-boost interval and heightened anti-GD2 antibody response to carbohydrate cancer vaccine
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Basu, E. M.; Feng, Y.; Kushner, B. H.; Cheung, N. K.
    Vaccines (2024)

    Fulltext@MSK | Save
  • Intraoperative radiation therapy for relapsed or refractory high-risk neuroblastoma: A 27-year experience
    Journal Article

    Conte, B.; Casey, D. L.; Tringale, K. R.; Honeyman, J.; Narayan, N. J. C.; LaQuaglia, M. P.; Gerstle, J. T.; Modak, S.; Kushner, B. H.; Kramer, K.; more...
    Practical Radiation Oncology (2024)

    Fulltext@MSK | Save
  • Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells
    Journal Article

    Yankelevich, M.; Thakur, A.; Modak, S.; Chu, R.; Taub, J.; Martin, A.; Schalk, D.; Schienshang, A.; Whitaker, S.; Rea, K.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastoma
    Review

    Mora, J.; Modak, S.; Kinsey, J.; Ragsdale, C. E.; Lazarus, H. M.
    International Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Case study #2: Disialoganglioside GD2 as a target for radiopharmaceutical therapy
    Book Section

    Cheung, N. K. V.; Kramer, K.; Modak, S.; Kushner, B. H.; Ahmed, M.; Santich, B.; Cheal, S.; Larson, S.
    In Bodei, L.; Lewis, J. S.; Zeglis, B. M. (Eds.) Radiopharmaceutical Therapy (2023)

    Fulltext@MSK | Save
  • Anaplastic lymphoma kinase inhibitors for therapy of neuroblastoma in adults
    Journal Article

    Stiefel, J.; Kushner, B. H.; Roberts, S. S.; Iglesias-Cardenas, F.; Kramer, K.; Modak, S.
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • 18F-MFBG PET imaging in patients with neuroblastoma: Lesion targeting and comparison with MIBG
    Meeting Abstract

    Pandit-Taskar, N.; Mauguen, A.; Basu, E.; Price, A.; Behr, G.; Min, R.; Lyashchenko, S.; Schwartz, J.; Modak, S.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Stage 4N neuroblastoma before and during the era of anti-G(D2) immunotherapy
    Journal Article

    Kushner, B. H.; LaQuaglia, M. P.; Cardenas, F. I.; Basu, E. M.; Gerstle, J. T.; Kramer, K.; Roberts, S. S.; Wolden, S. L.; Cheung, N. K. V.; Modak, S.
    International Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Gut microbiota associations with GD2/GD3 vaccine response in patients with high-risk neuroblastoma
    Meeting Abstract

    Miltiadous, O.; Nguyen, C.; Cheung, I.; Kushner, B.; Mauguen, A.; Waters, N.; Dai, A.; Kivovich, V.; Littmann, E.; Harford, L.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of naxitamab plus modified dosing of GM-CSF for patients with high-risk neuroblastoma (HR-NB) in first complete remission (CR) or with primary refractory disease
    Meeting Abstract

    Kushner, B. H.; Modak, S.; Basu, E. M.; Iglesias Cardenas, F.; Kramer, K.; Roberts, S. S.; Cheung, N. K. V.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save